2,247 Shares in Stryker Corporation $SYK Acquired by E Fund Management Co. Ltd.

E Fund Management Co. Ltd. acquired a new position in shares of Stryker Corporation (NYSE:SYK) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 2,247 shares of the medical technology company’s stock, valued at approximately $707,000.

Other institutional investors also recently added to or reduced their stakes in the company. Sachem Hill LLC purchased a new stake in Stryker during the second quarter valued at approximately $531,000. Notis McConarty Edward acquired a new position in shares of Stryker during the second quarter worth $978,000. Northcape Wealth Management LLC purchased a new stake in shares of Stryker during the 2nd quarter valued at $2,747,000. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of Stryker during the 2nd quarter valued at $44,000. Finally, Strathmore Capital Advisors Inc. acquired a new stake in shares of Stryker in the 2nd quarter worth $397,000. Institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on SYK. Barclays dropped their price target on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Canaccord Genuity Group lowered their target price on shares of Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, May 1st. The Goldman Sachs Group reissued a “neutral” rating and set a $361.00 target price on shares of Stryker in a research report on Friday, May 1st. Argus set a $370.00 price target on shares of Stryker in a research note on Thursday, July 9th. Finally, Leerink Partners lowered their price objective on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Insider Activity at Stryker

In other news, insider Debra King sold 826 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider owned 6,210 shares of the company’s stock, valued at $2,088,423. This represents a 11.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Robert S. Fletcher sold 4,544 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the sale, the vice president owned 10,582 shares in the company, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 315,370 shares of company stock valued at $98,463,501. 4.60% of the stock is owned by company insiders.

Stryker Stock Performance

NYSE SYK opened at $340.20 on Thursday. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $130.49 billion, a price-to-earnings ratio of 35.25, a PEG ratio of 2.11 and a beta of 0.76. The stock has a 50-day moving average of $326.19 and a 200 day moving average of $332.95. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86.

Stryker (NYSE:SYK) last released its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter in the previous year, the company earned $3.13 earnings per share. The company’s quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Sell-side analysts anticipate that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Wednesday, September 30th. Stryker’s payout ratio is currently 36.48%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.